Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Thermostabilization of panomycocin, a novel exo-beta-1,3-glucanase isolated from pichia anomala NCYC 434, by using excipients and computational methods
Download
index.pdf
Date
2015
Author
Muhammed, Muhammed Tilahun
Metadata
Show full item record
Item Usage Stats
171
views
66
downloads
Cite This
As the risks for fungal infections increased, the prevalence of invasive fungal infections increased. Therefore, the demand for antifungal agents has risen. Moreover, the currently used antifungal agents have serious side effects and resistance development resulting from their mechanisms of action. Thus, novel antifungal agents with mechanisms that will not affect the host mammalian cells are in need. Yeast killer proteins which are naturally occuring toxins are good candidates for such types of agents. Panomycocin is an example for this type of killer proteins. Panomycocin is a killer toxin of Pichia anomala NCYC 434 (K5). It has exo-β-1,3-glucanase activity. It kills the sensitive cells by hydrolyzing β-1,3-glucans that are crucial in maintaining the integrity of fungal cell wall. However, its activity decreases above 37ºC. In this work various types of excipients were used to increase the thermostability of Panomycocin so that it would be active at higher temperatures. Gradient concentrations of these excipients along with the protein were tested on Saccharomyces cerevisiae NCYC 1006 at increasing temperatures. If the excipients tested increase the thermostability, this will give us the opportunity to choose suitable excipients that can be used in the formulation of Panomycocin as a novel antifungal drug. Since the effect of excipients on thermostability is limited, computational methods were also used to design a thermostable protein at much higher temperatures. Homology modeling of the protein was performed first. After the binding site of the protein was predicted, the best thermostabilizing positions in the model generated were detected utilizing various computer programs and servers. Although the excipients tested did not increase the thermostability of the protein, we found the best amino acid residues in the model whose substitutions can increase the thermostability of the protein to the desired level. In the allosteric part of the protein Leu52Arg, Phe223Arg and Gly254Arg were found to be the best thermostabilizing mutations with 6.26 K, 6.26 K and 8.27 K temperature increases respectively. In the binding site Glu186Arg was found to be the best thermostabilizer mutation with 9.58 K temperature increase. Using the results mutant thermostable protein can be obtained and this will enable the formulation of Panomycocin as a novel antifungal drug with high thermostability.
Subject Keywords
Panomycocin.
,
Excipients.
,
Homology (Biology).
,
Stabilizing agents.
,
Antifungal agents.
URI
http://etd.lib.metu.edu.tr/upload/12619668/index.pdf
https://hdl.handle.net/11511/25375
Collections
Graduate School of Natural and Applied Sciences, Thesis
Suggestions
OpenMETU
Core
In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods
Gursel, I; Yagmurlu, F; Korkusuz, F; Hasırcı, Vasıf Nejat (2002-03-01)
Provision and maintenance of adequate concentrations of antibiotics at infection sites is very important in treating highly resistant infections. For diseases like implant related osteomyelitis (IRO) it is best to provide this locally via implanted drug formulations, as systemic administration of the antibiotic may not be effective due to damaged vasculature. In this study, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) rods containing 7, 14 and 22% (mol) 3-hydroxyvalerate were loaded with sulbactam:ce...
Fabrication and in vitro characterization of antibacterial magneto-luminescent core-shell bioactive glass nanoparticles
Unal, Fatma; Tasar, Cansu; Ercan, Batur (2023-01-01)
When nanomaterials with antibacterial properties were sent to the infected area, it was predicted that infection and related complications could be prevented. The nanoparticles can be designed to possess magnetic and luminescence (magneto-luminescent) properties to be effectively targeted and localized at the infection foci without dispersing into the body. Simultaneously, the magneto-luminescent characteristic of particles allows visualization and confirmation of localized particles at the desired area. In...
Thermodynamics of aminoglycoside binding to aminoglycoside-3 '-phosphotransferase IIIa studied by isothermal titration calorimetry
Özen, Can (2004-11-23)
The aminoglycoside-3'-phosphotransferase IIIa [APH(3')-IIIIa] phosphorylates aminoglycoside antibiotics and renders them ineffective against bacteria. APH(3')-IIIa is the most promiscuous aminoglycoside phosphotransferase enzyme, and it modifies more than 10 different aminoglycoside antibiotics. A wealth of information exists about the enzyme; however, thermodynamic properties of enzyme-aminoglycoside complexes are still not known. This study describes the determination of the thermodynamic parameters of th...
Backbone resonance assignments of a promiscuous aminoglycoside antibiotic resistance enzyme; the aminoglycoside phosphotransferase(3')-IIIa
Serpersu, Engin H.; Özen, Can; Norris, Adrianne L.; Steren, Carlos; Whittemore, Neil (2010-04-01)
The aminoglycoside phosphotransferase(3')-IIIa (APH) is a promiscuous enzyme and renders a large number of structurally diverse aminoglycoside antibiotics useless against infectious bacteria. A remarkable property of this similar to 31 kDa enzyme is in its unusual dynamic behavior in solution; the apo-form of the enzyme exchanges all of its backbone amide protons within 15 h of exposure to D (2) O while aminoglycoside-bound forms retain similar to 40% of the amide protons even after > 90 h of exposure. More...
Panomycocin-incorporated chitosan-tpp nanoparticles : preparation, characterization and in vitro determination of antifungal activity against human dermatophytes
Elçin, Evrim; İzgü, Kadri Fatih; Department of Biotechnology (2013)
There is an increase in the incidence of superficial fungal infections. Especially, immuno-compromised patients, diabetic patients, obese and people having resistancy against a group of antifungal drugs are at great risk. In these patient groups the infection can become chronic and affect the deeper and living layers of the skin and can be life threatening if not treated effectively. However, drugs which are currently used in the therapy of dermatophyte infections are becoming less effective due to the seri...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
M. T. Muhammed, “Thermostabilization of panomycocin, a novel exo-beta-1,3-glucanase isolated from pichia anomala NCYC 434, by using excipients and computational methods,” M.S. - Master of Science, Middle East Technical University, 2015.